GlassScriptPhysician profile
Toni V Centanni
NPI 1700832649
$532.75
in general payments reported to CMS, 2019-2025
14 companies · $73.22 in 2025
The $73.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.04 · 2021: $13.22 · 2022: $38.35 · 2023: $157 · 2024: $159 · 2025: $73.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.79 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $105.84 | 2019-2023 | Lo Loestrin Fe |
| Millicent US INC | $68.27 | 2023-2024 | Intrarosa, Femring |
| Exeltis, USA INC. | $66.94 | 2022-2024 | Slynd |
| Pfizer INC. | $51.53 | 2024 | |
| Astellas Pharma US INC | $40.33 | 2024 | Veozah |
| Meditrina | $40.14 | 2023 | |
| Novo Nordisk INC | $38.89 | 2024-2025 | Wegovy |
| Ethicon US, LLC | $24.60 | 2022 | |
| Solventum Corporation | $18.10 | 2025 | Prevena |
| Evofem Biosciences, INC. | $16.91 | 2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $16.50 | 2023 | Nexplanon |
| Sage Therapeutics, LLC | $15.94 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $15.54 | 2023 | |
| Agile Therapeutics, INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toni Centanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.